Abrocitinib: Uses, Side Effects, and Drug Interactions

Brand names: CIBINQO

# Abrocitinib Overview Abrocitinib is a medicine used to treat moderate to severe atopic dermatitis, which is a skin condition that causes itching, redness, and irritation. It works by reducing inflammation in the body and helping to calm down the immune system's reaction that causes these uncomfortable skin problems. This medication comes as a tablet that you take by mouth, usually once a day. Your doctor will decide the right dose for you based on how well the medicine works and how your body responds to it. Before taking abrocitinib, it's important to tell your doctor about all other medicines you're taking, because some drugs can interact with it and change how well it works. Your doctor may need to adjust your dose or watch you more carefully if you're taking certain other medications. Like all medicines, abrocitinib can cause side effects, so it's important to discuss possible risks with your doctor and report any unusual symptoms while taking this medication. Always follow your doctor's instructions about when and how to take this medicine, and don't stop taking it without talking to your doctor first.

Taking Abrocitinib with other medications?

Check Abrocitinib against any other medication — the form below is already pre-filled.

Check Now ↓

Most Reported Side Effects (FAERS)

  • DRUG INEFFECTIVE509 reports
  • CONDITION AGGRAVATED351 reports
  • OFF LABEL USE304 reports
  • PRURITUS228 reports
  • THERAPEUTIC PRODUCT EFFECT INCOMPLETE204 reports
  • RASH170 reports
  • DERMATITIS ATOPIC160 reports
  • NAUSEA148 reports
  • HEADACHE99 reports
  • ECZEMA87 reports

Source: FDA Adverse Event Reporting System (FAERS). Voluntary reports do not establish causation.

Check interactions with Abrocitinib:

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.